Developer docs
API playgroundTry for free, no card

Search company profiles

CRG

Full company profile

uuid0000i63

Namestring
CRG
Legal namestring
CR Group L.P.
Websiteurl
crglp.com
Company typeenum
Private
Founded yearint
2003
Descriptiontext

CRG (CR Group L.P.) is a Houston, Texas-based private credit and investment firm founded in 2003 that exclusively finances healthcare companies across three sub-sectors: consumer health, life sciences, and healthcare services & IT. The firm manages over $4 billion in institutional capital and has executed more than 80 credit investments over its operating history, with a stated strategy of providing senior secured first-lien term loans ranging from $20 million to $300 million, supplemented by selective equity exposure in portfolio companies.

The firm is led by a Founders Group comprising Managing Partner Nate Hukill, Chief Investment Officer Luke Düster, and Partner David Carter, who together with Partner Scott Li anchor the investment committee. CRG maintains offices in Houston (headquarters), Boulder, and New York, and employs between 11 and 50 people. The leadership team brings 175+ years of collective experience across healthcare, private equity, capital markets, and operations, and senior leadership has worked together for 16+ years.

CRG's revenue model is based on management fees and incentive economics derived from its institutional fund vehicles, with investment returns generated primarily through senior secured debt service and secondarily through equity participation. Deal sourcing is proprietary and relationship-driven: companies are typically tracked for approximately three years before investment, with outreach conducted through direct negotiation rather than competitive auctions. The firm is a signatory to the UN-supported Principles for Responsible Investing and maintains a dedicated ESG governance structure. As a Delaware limited partnership, CRG is privately held with no public listing, no disclosed parent company, and no material M&A activity in its history.

Short descriptiontext

CRG is a Houston-based private credit firm founded in 2003 that exclusively finances healthcare companies via senior secured term loans of $20M–$300M, managing over $4 billion in institutional capital across consumer health, life sciences, and healthcare services & IT.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersHouston, United States
HQ citystring
Houston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare private credit, senior secured loans, growth capital financing, biopharmaceutical investments, healthcare venture debt
Industry1 code
1Real Estate Private Credit (CRE Debt)
CodeFSANADAGPrimaryYes
NAICS code1 code
  • Credit Intermediation and Related Activities522
SIC code1 code
  • Miscellaneous Business Credit Institution6159
Product category
Healthcare Private Credit
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Credit Investments
TypeSubscription Recurring
Description

CRG primarily provides senior secured first-lien term loans to healthcare companies, generating returns through interest payments and principal repayment. Loans are structured to minimize dilution while supporting portfolio company growth objectives.

crglp.com
2Select Equity Investments
TypeSubscription Recurring
Description

In certain cases, CRG supplements debt investments with equity exposure in various forms to align interests and capture upside potential in portfolio companies.

crglp.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

CRG provides non-dilutive, senior secured first-lien term loans ranging from $20 million to $300 million to mid-to-large healthcare companies across consumer health, life sciences, and healthcare services & IT sectors. The firm supplements these credit investments with select equity exposures to align interests and capture upside, and structures flexible, custom-tailored financing solutions for healthcare companies needing growth capital for product launches, market expansion, acquisitions, and R&D. CRG manages over $4 billion in institutional capital and has executed 80+ healthcare credit investments over its 15+ year track record.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

CRG (CR Group L.P.) is a premier healthcare investment firm offering a suite of financing products centered around flexible growth capital solutions. The core offering is non-dilutive senior secured term loans ranging from $20M to $300M, supplemented by select equity investments for healthcare companies across three sub-sectors: Consumer Health (wearables, consumer health products), Life Sciences (biopharma, medical devices, diagnostics), and Healthcare Services & IT (telemedicine, healthcare services, tech-enabled delivery). The investment strategy emphasizes long-term partnership, with all investments aligned to improving patient lives, reducing healthcare costs, or expanding access to care.

Product and service4 records
1Healthcare Growth Capital
CategoryHealthcare Private Credit / Term Loans
Description

Non-dilutive growth capital provided to healthcare companies as senior secured first-lien term loans, designed to minimize equity dilution while supporting product launches, market expansions, acquisitions, and strategic R&D initiatives. Targets mid-to-large healthcare companies in consumer health, life sciences, and healthcare services & IT.

2Flexible Financing Solutions
CategoryHealthcare Private Credit / Structured Finance
Description

Custom-tailored, case-by-case structured financing solutions offering greater flexibility and fewer restrictions than traditional funding sources. Positions CRG as a trusted long-term partner providing strategic support beyond capital deployment.

3Credit Investments
CategorySenior Secured Term Loans
Description

Primary investment strategy involving senior secured term loans to healthcare portfolio companies. Returns are generated through interest payments and principal repayment, with first-lien collateral positions designed to minimize risk while supporting growth objectives.

4Equity Investments
CategoryEquity Capital
Description

Select equity investments made alongside primary credit investments to align interests with portfolio companies and capture upside potential. Supplements debt financing with various forms of equity exposure in healthcare companies.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Hercules Capital is the largest publicly traded specialty finance company focused on providing senior secured venture debt to venture capital-backed and institutional-backed companies, with deep healthcare and life sciences exposure. Directly comparable to CRG given its senior-secured loan structure, healthcare sector focus, and similar ticket sizes, though Hercules is significantly larger and publicly traded.

TypeDirect peer
Description

Oxford Finance is a private specialty finance firm exclusively dedicated to healthcare and life sciences lending, providing senior secured loans to healthcare companies across devices, diagnostics, and services. Closely comparable to CRG in exclusive healthcare focus, senior secured structure, and mid-market healthcare deal profile.

TypeDirect peer
Description

Athyrium is a specialized investment manager focused exclusively on healthcare credit opportunities, including royalty financing, direct lending, and specialty credit across the healthcare ecosystem. Closely comparable to CRG in healthcare-only credit focus, with somewhat differentiated product mix (greater emphasis on royalty/structured credit).

TypeDirect peer
Description

Innovatus is an institutional investment firm focused on providing asset-based financing and specialty credit solutions to healthcare companies, including second-lien and stretch senior secured loans. Comparable to CRG in healthcare credit specialization and tailored financing structures, with somewhat more asset-based orientation.

TypeDirect peer
Description

HealthCare Royalty Partners is a healthcare-focused investment firm that provides capital to healthcare companies and inventors through royalty and structured credit transactions. Comparable to CRG in healthcare-only focus and non-dilutive financing, with product mix tilted more toward royalty/milestone payments than CRG's senior secured term loans.

TypeDirect peer
Description

Horizon Technology Finance is a specialty finance company providing secured loans to venture capital-backed companies in technology, life science, healthcare, and sustainability. Comparable to CRG via senior secured venture debt structure and meaningful healthcare/life sciences exposure, though Horizon is broader across technology.

TypeDirect peer
Description

Trinity Capital is a specialty lending provider that offers senior secured loans to growth-stage companies across technology, healthcare, and other sectors. Comparable to CRG via senior secured structure and healthcare lending, though Trinity is publicly traded and broader across industries.

TypeDirect peer
Description

K2 HealthVentures is a healthcare-focused specialty finance firm providing debt capital to growth and late-stage healthcare companies across life sciences, medical devices, and healthcare services. Directly comparable to CRG in healthcare-only focus and growth-stage healthcare lending profile.

TypeDirect peer
Description

Perceptive Advisors is a healthcare-focused investment firm managing credit, royalty, and venture strategies across biotech, medical devices, and digital health. Comparable to CRG in healthcare-only credit specialization and life sciences deal flow, with a larger and more diversified product set (including public credit and equities).

TypeEmerging player
Description

Solar Capital Partners is a middle-market private credit manager providing senior secured financing across diversified industries including healthcare. Comparable to CRG in senior-secured loan product and ticket size, with more diversified sector exposure.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles25 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment64 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CRG

Healthcare Private Creditcrglp.com

CRG is a Houston-based private credit firm founded in 2003 that exclusively finances healthcare companies via senior secured term loans of $20M–$300M, managing over $4 billion in institutional capital across consumer health, life sciences, and healthcare services & IT.

What CRG does

CRG (CR Group L.P.) is a Houston, Texas-based private credit and investment firm founded in 2003 that exclusively finances healthcare companies across three sub-sectors: consumer health, life sciences, and healthcare services & IT. The firm manages over $4 billion in institutional capital and has executed more than 80 credit investments over its operating history, with a stated strategy of providing senior secured first-lien term loans ranging from $20 million to $300 million, supplemented by selective equity exposure in portfolio companies.

The firm is led by a Founders Group comprising Managing Partner Nate Hukill, Chief Investment Officer Luke Düster, and Partner David Carter, who together with Partner Scott Li anchor the investment committee. CRG maintains offices in Houston (headquarters), Boulder, and New York, and employs between 11 and 50 people. The leadership team brings 175+ years of collective experience across healthcare, private equity, capital markets, and operations, and senior leadership has worked together for 16+ years.

CRG's revenue model is based on management fees and incentive economics derived from its institutional fund vehicles, with investment returns generated primarily through senior secured debt service and secondarily through equity participation. Deal sourcing is proprietary and relationship-driven: companies are typically tracked for approximately three years before investment, with outreach conducted through direct negotiation rather than competitive auctions. The firm is a signatory to the UN-supported Principles for Responsible Investing and maintains a dedicated ESG governance structure. As a Delaware limited partnership, CRG is privately held with no public listing, no disclosed parent company, and no material M&A activity in its history.

CRG firmographics

Firmographics
Name
CRG
Legal name
CR Group L.P.
Website
https://crglp.com
Company type
Private
Founded year
2003
Operating status
Operating
Headcount range
501–1,000 employees
Short description
CRG is a Houston-based private credit firm founded in 2003 that exclusively finances healthcare companies via senior secured term loans of $20M–$300M, managing over $4 billion in institutional capital across consumer health, life sciences, and healthcare services & IT.
Ownership category
akta.pro rank

CRG industry classification

Industry
Product category
Healthcare Private Credit
NAICS
Credit Intermediation and Related Activities (522)
SIC
Miscellaneous Business Credit Institution (6159)
akta.pro primary industry
Real Estate Private Credit (CRE Debt) (FSANADAG)

Keywords

  • Healthcare private credit
  • Senior secured loans
  • Growth capital financing
  • Biopharmaceutical investments
  • Healthcare venture debt

Where CRG is headquartered

Location

Headquarters

HQ city
Houston
HQ country
United States
HQ region
North America

Offices3 records

Markets served

CRG business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Credit Investments: CRG primarily provides senior secured first-lien term loans to healthcare companies, generating returns through interest payments and principal repayment. Loans are structured to minimize dilution while supporting portfolio company growth objectives.
  2. Select Equity Investments: In certain cases, CRG supplements debt investments with equity exposure in various forms to align interests and capture upside potential in portfolio companies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

CRG product offering

Product offering

Core offering

CRG provides non-dilutive, senior secured first-lien term loans ranging from $20 million to $300 million to mid-to-large healthcare companies across consumer health, life sciences, and healthcare services & IT sectors. The firm supplements these credit investments with select equity exposures to align interests and capture upside, and structures flexible, custom-tailored financing solutions for healthcare companies needing growth capital for product launches, market expansion, acquisitions, and R&D. CRG manages over $4 billion in institutional capital and has executed 80+ healthcare credit investments over its 15+ year track record.

Product overview

CRG (CR Group L.P.) is a premier healthcare investment firm offering a suite of financing products centered around flexible growth capital solutions. The core offering is non-dilutive senior secured term loans ranging from $20M to $300M, supplemented by select equity investments for healthcare companies across three sub-sectors: Consumer Health (wearables, consumer health products), Life Sciences (biopharma, medical devices, diagnostics), and Healthcare Services & IT (telemedicine, healthcare services, tech-enabled delivery). The investment strategy emphasizes long-term partnership, with all investments aligned to improving patient lives, reducing healthcare costs, or expanding access to care.

Differentiator

Problem solved

Functional benefit

Products and services

  • Healthcare Growth Capital Non-dilutive growth capital provided to healthcare companies as senior secured first-lien term loans, designed to minimize equity dilution while supporting product launches, market expansions, acquisitions, and strategic R&D initiatives. Targets mid-to-large healthcare companies in consumer health, life sciences, and healthcare services & IT.
  • Flexible Financing Solutions Custom-tailored, case-by-case structured financing solutions offering greater flexibility and fewer restrictions than traditional funding sources. Positions CRG as a trusted long-term partner providing strategic support beyond capital deployment.
  • Credit Investments Primary investment strategy involving senior secured term loans to healthcare portfolio companies. Returns are generated through interest payments and principal repayment, with first-lien collateral positions designed to minimize risk while supporting growth objectives.
  • Equity Investments Select equity investments made alongside primary credit investments to align interests with portfolio companies and capture upside potential. Supplements debt financing with various forms of equity exposure in healthcare companies.

Companies that use CRG

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles2 records

CRG technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

CRG partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

CRG competitors and assessment

Company assessment

Direct peers

  • Hercules Capital: Hercules Capital is the largest publicly traded specialty finance company focused on providing senior secured venture debt to venture capital-backed and institutional-backed companies, with deep healthcare and life sciences exposure. Directly comparable to CRG given its senior-secured loan structure, healthcare sector focus, and similar ticket sizes, though Hercules is significantly larger and publicly traded.
  • Oxford Finance: Oxford Finance is a private specialty finance firm exclusively dedicated to healthcare and life sciences lending, providing senior secured loans to healthcare companies across devices, diagnostics, and services. Closely comparable to CRG in exclusive healthcare focus, senior secured structure, and mid-market healthcare deal profile.
  • Athyrium Capital Management: Athyrium is a specialized investment manager focused exclusively on healthcare credit opportunities, including royalty financing, direct lending, and specialty credit across the healthcare ecosystem. Closely comparable to CRG in healthcare-only credit focus, with somewhat differentiated product mix (greater emphasis on royalty/structured credit).
  • Innovatus Capital Partners: Innovatus is an institutional investment firm focused on providing asset-based financing and specialty credit solutions to healthcare companies, including second-lien and stretch senior secured loans. Comparable to CRG in healthcare credit specialization and tailored financing structures, with somewhat more asset-based orientation.
  • HealthCare Royalty Partners: HealthCare Royalty Partners is a healthcare-focused investment firm that provides capital to healthcare companies and inventors through royalty and structured credit transactions. Comparable to CRG in healthcare-only focus and non-dilutive financing, with product mix tilted more toward royalty/milestone payments than CRG's senior secured term loans.
  • Horizon Technology Finance: Horizon Technology Finance is a specialty finance company providing secured loans to venture capital-backed companies in technology, life science, healthcare, and sustainability. Comparable to CRG via senior secured venture debt structure and meaningful healthcare/life sciences exposure, though Horizon is broader across technology.
  • Trinity Capital: Trinity Capital is a specialty lending provider that offers senior secured loans to growth-stage companies across technology, healthcare, and other sectors. Comparable to CRG via senior secured structure and healthcare lending, though Trinity is publicly traded and broader across industries.
  • K2 HealthVentures: K2 HealthVentures is a healthcare-focused specialty finance firm providing debt capital to growth and late-stage healthcare companies across life sciences, medical devices, and healthcare services. Directly comparable to CRG in healthcare-only focus and growth-stage healthcare lending profile.
  • Perceptive Advisors: Perceptive Advisors is a healthcare-focused investment firm managing credit, royalty, and venture strategies across biotech, medical devices, and digital health. Comparable to CRG in healthcare-only credit specialization and life sciences deal flow, with a larger and more diversified product set (including public credit and equities).

Emerging players

  • Solar Capital Partners: Solar Capital Partners is a middle-market private credit manager providing senior secured financing across diversified industries including healthcare. Comparable to CRG in senior-secured loan product and ticket size, with more diversified sector exposure.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

CRG social profiles

Digital presence

CRG compliance and trust

Trust signal

Compliance1 record

CRG financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CRG leadership team

Management profile

Number of profiles

Profiles25 records

CRG funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CRG M&A and investment

M&A and investment

M&A

Investments64 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CRG

What does CRG do?

CRG provides non-dilutive, senior secured first-lien term loans ranging from $20 million to $300 million to mid-to-large healthcare companies across consumer health, life sciences, and healthcare services & IT sectors. The firm supplements these credit investments with select equity exposures to align interests and capture upside, and structures flexible, custom-tailored financing solutions for healthcare companies needing growth capital for product launches, market expansion, acquisitions, and R&D. CRG manages over $4 billion in institutional capital and has executed 80+ healthcare credit investments over its 15+ year track record.

Is CRG a public or private company?

CRG is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was CRG founded?

CRG was founded in 2003. It employs 501 to 1,000 people.

Where is CRG based?

CRG is headquartered in Houston, United States, in the North America region.

How does CRG make money?

Two revenue lines are on record. Credit Investments are the primary driver. The others are select Equity Investments.

Who are CRG's main competitors?

Direct peers on record are Hercules Capital, Oxford Finance, Athyrium Capital Management, Innovatus Capital Partners, HealthCare Royalty Partners, Horizon Technology Finance, Trinity Capital, K2 HealthVentures and Perceptive Advisors. Solar Capital Partners is listed as an emerging player.

Does CRG have an API?

No public API is recorded for CRG.

What industry is CRG in?

CRG's product category is Healthcare Private Credit. Its primary akta.pro industry code is FSANADAG, Real Estate Private Credit (CRE Debt). Its NAICS code is 522 and its SIC code is 6159.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
TechSpotMissouri town ousts half of its city council after $6 billion AI data center approvalFestus, Missouri voters removed all four incumbent city council members up for reelection, changing half of the eight-seat council one week after those members approved a $6 billion AI data center development by CRG, part of Chicago-based construction firm Clayco. The project, spanning roughly 360 acres, faced unified opposition from more than two dozen residents at a March 30 meeting over property value concerns and a voluntary buyout program. A lawsuit filed by Wake Up Jeffco and nearby property owners seeks to invalidate the city's approval, while residents are backing a petition to remove the mayor and remaining council members.TechStartupsSecurity Risk Advisors Purple Team Participants Can Now Earn CPE CreditsSecurity Risk Advisors announced that its Purple Team exercises now earn CPE credits from GIAC and ISC2. Each 15-hour engagement yields up to 15 CPE credits per participant, with certificates issued from April 2026. Participants must attend at least 80% of sessions.TechStartupsTop Startup and Tech Funding News – April 14 2025On April 14, 2026, multiple startups raised funding across AI infrastructure, biotech, and enterprise software. Glydways led with a $170M Series C, followed by Sygaldry's $105M Series A and nEye.ai's $80M Series C. The rounds signal investor focus on AI infrastructure and agentic systems.TechStartupsAmazon acquires Globalstar for $11.6B, taking direct aim at SpaceX’s StarlinkAmazon agreed to acquire satellite operator Globalstar for about $11.57 billion, integrating its operations into its Leo satellite internet program. The deal, expected to close in 2027, gives Amazon control of Globalstar's spectrum and infrastructure, aiming to roll out direct-to-device connectivity by 2028. The acquisition puts Amazon on a direct collision course with SpaceX's Starlink, which leads the market.FinSMEsCalyxo Secures $40M in Series F FundingCalyxo, a Pleasanton-based medical device company, raised $40M in Series F funding led by Ally Bridge Group and Janus Henderson Investors. The company will use the funds to expand commercial infrastructure, advance clinical and health economic evidence, and support innovation in kidney stone care. Its CVAC System has treated approximately 40,000 patients.POLITICOMissouri town fires half its city council over data center dealVoters in Festus, Missouri ousted all four incumbent city council members last week in a recall-style election driven by public backlash against the council's approval of a $6 billion data center development agreement. The newly elected council will be sworn in Monday, and opponents have filed a lawsuit against the city and developer CRG (part of Chicago-based Clayco) challenging the rezoning, while also gathering signatures for a recall petition against the mayor and remaining council members. Port Washington, Wisconsin similarly voted to restrict future data center projects on the same day, with at least three other cities expected to vote on similar measures this year.STLPRFestus council approves $6 billion data center plan despite massive public pushbackThe Festus City Council in Missouri approved an ordinance (6-2 vote) establishing requirements for developer CRG to build a $6 billion data center on 360 acres north of Highway 67, despite hundreds of residents opposing the project at a packed public meeting where public comment was cut off after two hours. CRG, the data center arm of real estate developer Clayco, will pay the city $3 million annually for the first five years and $5 million annually for the next five years, with the city projecting the project could generate $80 million annually in tax revenue for Festus and nearby taxing districts despite a five-year tax abatement. The vote follows months of controversy including allegations that meetings with CRG were held without public knowledge, and opposition from residents who object to data centers being built near homes.The Washington PostTowns are saying no to AI data centers. One got sued over it.Related Digital, a data center developer, sued Saline Township, Michigan, after the town board rejected its proposal to build a 250-acre data center on farmland, ultimately forcing the township into a consent agreement that allows development while limiting water use and providing funds for local services. The case reflects a growing wave of local opposition to data center projects across the country, driven by residents' concerns about environmental impact, noise, and strain on local resources. St. Charles, Missouri, and Lordstown, Ohio, have pursued stricter measures—including moratoriums and proposed bans—in response to similar controversial proposals from developers like CRG and SoftBank's Stargate project.BfinanceDiagnosis: Opportunity? Direct Lending in Healthcarebfinance research shows healthcare direct lending strategies offering a median net IRR target of nearly 15%, representing a premium of more than 300 basis points over generalist US direct lending strategies, with higher returns not attributable to fund-level leverage. The healthcare lending sub-sector is expanding beyond historically small specialist boutiques like CRG and Pharmakon Advisors, with larger private credit managers including Ares and Oaktree launching dedicated strategies. The sector presents distinctive challenges including cashflow-light borrowers, a high proportion of unsponsored transactions with listed companies, esoteric deal structures, and significant ESG considerations around drug pricing and vulnerable patient populations.PharmiWeb.comAvinger Announces Conversion of $11 Million of CRG Debt into Preferred EquityAvinger, Inc. announced the conversion of $11 million of its existing debt held by entities affiliated with CRG Partners III L.P. into shares of a new series of convertible preferred stock. This transaction reduces the outstanding principal debt to $2.6 million and increases stockholders' equity by $11 million, aiming to help the company regain compliance with Nasdaq listing standards.